Marie-Pierre Dubé

Title: Marie-Pierre Dubé: Innovator in Genetic Predictors of INR Fluctuation

Introduction

Marie-Pierre Dubé is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of genetics, particularly in relation to warfarin therapy. Her innovative work focuses on identifying genetic predictors that can help manage the risks associated with abnormal international normalized ratio (INR) fluctuations during treatment.

Latest Patents

Marie-Pierre Dubé holds 1 patent for her invention titled "Genetic predictors of international normalized ratio (INR) fluctuation with warfarin therapy." This patent discloses methods and kits designed to identify subjects who possess genetic variations that predispose them to abnormal INR fluctuations while undergoing warfarin therapy. The methods involve testing for predetermined genetic variations correlated with these fluctuations, allowing for better management of patient care.

Career Highlights

Throughout her career, Marie-Pierre has worked with esteemed organizations such as the Institut De Cardiologie De Montreal and F. Hoffmann-La Roche AG. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to advancements in cardiovascular health.

Collaborations

Marie-Pierre has collaborated with notable colleagues, including Hannah Beattie and Jean-Claude Tardif. These partnerships have further enriched her research and innovation efforts.

Conclusion

Marie-Pierre Dubé's work in identifying genetic predictors of INR fluctuations represents a significant advancement in personalized medicine. Her contributions are vital for improving patient outcomes in warfarin therapy.